In all, this evidence suggests a “class-switch” from ErbB3 to EGFR/ErbB2 mediated ErbB signaling, mediated in part by collagen and fibronectin-stimulated integrin signaling, is a key mechanism promoting muscle-invasion of bladder tumors. Here, EGFR is linked to urinary bladder neoplasm.